UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSIO OF DUTY TO FILE REPORTS
UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 18, 2016
InoLife TECHNOLOGIES INC. |
(Exact Name of Registrant as Specified in Charter) |
New York
(State or Other Jurisdiction of Incorporation)
000-50863
(Commission File Number)
30-299889
(I.R.S. Employer Identification No.)
6040-A Six Forks Road, #135, Raleigh, NC 27609
(Address of Principal Executive Offices)
800-401-1996
(Issuer Telephone Number)
Common Stock, $0.00001 par value
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place and X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) | x | |
Rule 12g-4(a)(2) | ¨ | |
Rule 12h-3(b)(1)(i) | ¨ | |
Rule 12h-3(b)(1)(ii) | ¨ | |
Rule 15d-6 | ¨ |
Approximate number of holders of records as of the certification or notice date: 271
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
InoLife Technologies, Inc. | |||
Date: March 18, 2016 | By: | /s/ Dr. John Oda | |
Dr. John Oda | |||
Chief Executive Officer | |||
2
